Semaglutide, Tirzepatide and Clinically Recorded Alcohol‐Related Outcomes in Type 2 Diabetes: A Target Trial Emulation

Huilin Tang, Bingyu Zhang, Ying Lu, Yiwen Lu, Haoyuan Wang, Christal N. Davis, Henry R. Kranzler, Yong Chen

Open source

DOI
10.1111/dom.71470
Published
2026-11-03
Container
Diabetes, Obesity and Metabolism
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.71470,
  title = {Semaglutide, Tirzepatide and Clinically Recorded Alcohol‐Related Outcomes in Type 2 Diabetes: A Target Trial Emulation},
  author = {Huilin Tang and Bingyu Zhang and Ying Lu and Yiwen Lu and Haoyuan Wang and Christal N. Davis and Henry R. Kranzler and Yong Chen},
  year = {2026},
  journal = {Diabetes, Obesity and Metabolism},
  doi = {10.1111/dom.71470},
  url = {https://doi.org/10.1111/dom.71470}
}

RIS

TY  - JOUR
TI  - Semaglutide, Tirzepatide and Clinically Recorded Alcohol‐Related Outcomes in Type 2 Diabetes: A Target Trial Emulation
AU  - Huilin Tang
AU  - Bingyu Zhang
AU  - Ying Lu
AU  - Yiwen Lu
AU  - Haoyuan Wang
AU  - Christal N. Davis
AU  - Henry R. Kranzler
AU  - Yong Chen
PY  - 2026
JO  - Diabetes, Obesity and Metabolism
DO  - 10.1111/dom.71470
UR  - https://doi.org/10.1111/dom.71470
ER  - 

APA

Tang, H., Zhang, B., Lu, Y., Lu, Y., Wang, H., Davis, C. N., Kranzler, H. R., & Chen, Y. (2026). Semaglutide, Tirzepatide and Clinically Recorded Alcohol‐Related Outcomes in Type 2 Diabetes: A Target Trial Emulation. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71470

Source records